{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(9)"],"submitter":["Artale S"],"pubmed_abstract":["This study aimed to determine if dietary modifications using a nutritional regimen could prevent or reduce the incidence of cancer therapy-induced diarrhea in patients with metastatic colorectal cancer and to evaluate the relationship of Vitamin D blood levels with diarrhea severity. Patients with metastatic colorectal cancer were enrolled. A Mediterranean diet, containing some special limitations aiming to reduce the risk of diarrhea, was administered before and during the entire chemotherapy program. Enrolled patients numbering 60/137 (44%) had diarrhea during chemotherapy. Adherence to the diet was high in 36 (26.3%) patients, medium in 94 (68.6%), and low in 7 (5.1%). Mean adherence to the diet was significantly lower in patients who experienced diarrhea with maximum grade 2-3 compared"],"journal":["Nutrients"],"pagination":["1801"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9100930"],"repository":["biostudies-literature"],"pubmed_title":["A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer."],"pmcid":["PMC9100930"],"pubmed_authors":["Moroni M","Butti C","Artale S","Bovio A","Barbarini L","Colombo A","Antonelli P","Azzarello R","Pedrazzoli P","Serra F","Basciani S","Castiglioni E","Grillo N","Barzaghi S","Lepori S","Zanlorenzi L","Trojani A","Caccialanza R"],"additional_accession":[]},"is_claimable":false,"name":"A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer.","description":"This study aimed to determine if dietary modifications using a nutritional regimen could prevent or reduce the incidence of cancer therapy-induced diarrhea in patients with metastatic colorectal cancer and to evaluate the relationship of Vitamin D blood levels with diarrhea severity. Patients with metastatic colorectal cancer were enrolled. A Mediterranean diet, containing some special limitations aiming to reduce the risk of diarrhea, was administered before and during the entire chemotherapy program. Enrolled patients numbering 60/137 (44%) had diarrhea during chemotherapy. Adherence to the diet was high in 36 (26.3%) patients, medium in 94 (68.6%), and low in 7 (5.1%). Mean adherence to the diet was significantly lower in patients who experienced diarrhea with maximum grade 2-3 compared","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-05-31T23:36:29.809Z","creation":"2024-11-12T10:14:23.671Z"},"accession":"S-EPMC9100930","cross_references":{"pubmed":["35565769"],"doi":["10.3390/nu14091801"]}}